Atlanta, GA, United States of America

Anthony Edward Soscia

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Anthony Edward Soscia

Introduction

Anthony Edward Soscia is a notable inventor based in Atlanta, GA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of tamper-resistant drug delivery systems. With a total of four patents to his name, Soscia's work focuses on enhancing the safety and efficacy of therapeutic agents.

Latest Patents

One of his latest patents is titled "Dosage forms for tamper prone therapeutic agents." This innovative dosage form is designed to reduce or retard the burst release of a drug contained within a tampered dosage form. The invention incorporates a Tamper Prone Therapeutic Agent (TPTA) trap, which does not significantly interfere with the drug's release if the dosage form remains untampered. However, if tampering occurs, the TPTA trap effectively mitigates the risk of a rapid drug release, thereby enhancing patient safety.

Career Highlights

Soscia is currently employed at Atlantic Pharmaceuticals, Inc., where he continues to develop groundbreaking pharmaceutical technologies. His work is instrumental in addressing the challenges posed by drug tampering, which is a growing concern in the healthcare industry.

Collaborations

Throughout his career, Soscia has collaborated with talented individuals such as Yingxu Peng and Yichun Sun. These partnerships have contributed to the advancement of his innovative projects and have fostered a collaborative environment for research and development.

Conclusion

Anthony Edward Soscia's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving drug safety and efficacy. His work at Atlantic Pharmaceuticals, Inc. continues to pave the way for advancements in tamper-resistant drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…